Allan Kengo

5PUBLICATIONS
19CO-AUTHORS
Epidemiological modellingPharmacogenomicsBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 12, 2025
Model-based evaluation of the interaction between ritonavir-boosted atazanavir and rifampicin in Ugandan adults with HIV.

Allan Kengo, Juan Eduardo Resendiz-Galvan, Letisha Najjemba

|Feb 01, 2025
Intracellular Penetration of Atazanavir, Ritonavir and Dolutegravir With Concomitant Rifampicin: A Dose Escalation Study.

Amedeo De Nicolò, Alice Palermiti, Henry Mugerwa

|Apr 10, 2024
Assessing potential drug-drug interactions between clofazimine and other frequently used agents to treat drug-resistant tuberculosis.

Allan Kengo, Firdaus Nabeemeeah, Paolo Denti

|Oct 18, 2023
Dolutegravir pharmacokinetics in Ugandan patients with TB and HIV receiving standard- versus high-dose rifampicin.

Allan Kengo, Ruth Nabisere, Kamunkhwala Gausi

|Oct 18, 2023
Unexpectedly low drug exposures among Ugandan patients with TB and HIV receiving high-dose rifampicin.

Allan Kengo, Kamunkhwala Gausi, Ruth Nabisere

Pageof 1